SNAP-8 / Acetyl Octapeptide-3

ID: snap8

Aliases: SNAP-8, acetyl octapeptide-3, acetyl octapeptide

Type: compound

Route/form: topical or cosmetic microneedle formulation context; not systemic/injectable evidence

Status: cosmetic

Evidence level: early human

Best data tier: early human

Support scope: human, review/regulatory

Source types: human_trial, review

Linked sources: 2

Broad outcomes: Skin / wound repair

Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.

Targets / mechanism

• SNARE/neurotransmitter-release mimicry hypothesis
• facial wrinkle appearance endpoints
• topical or microneedle delivery context

Optimization domains

• skin
• aesthetics
• cosmetic
• wrinkles

Research basis

• Human cosmetic microneedle/peptide formulation data exist for anti-wrinkle endpoints.
• Mechanism is commonly framed as a topical botulinum-like neurotransmission-modulating peptide claim.

Limits, risks, and missing evidence

• Evidence is cosmetic-product/formulation specific, not systemic peptide biology.

Risk flags

• cosmetic evidence context
• formulation specific
• route specific evidence
• not systemic evidence

Linked papers, labels, and reviews

1. Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: a monocentric clinical study
   human_trial / pubmed_snap8_microneedle_2020
   Cosmetic peptide microneedle study including acetyl octapeptide-3/SNAP-8-style anti-wrinkle mechanism.
2. Acetyl Hexapeptide-8 in cosmeceuticals: a review of skin permeability and efficacy
   review / pubmed_cosmetic_peptides_review_2023
   Mechanistic/cosmeceutical background for SNAP-25 mimic peptide claims; SNAP-8 itself has thinner independent literature than acetyl hexapeptide-8.